Historical Valuation
Maravai LifeSciences Holdings Inc (MRVI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.51 is considered Undervalued compared with the five-year average of 1168.03. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 49.43 to 53.48 according to relative valuation methord. Compared to the current price of 3.91 USD , Maravai LifeSciences Holdings Inc is Undervalued By 92.09%.
Relative Value
Fair Zone
49.43-53.48
Current Price：3.91
92.09%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Maravai LifeSciences Holdings Inc (MRVI) has a current Price-to-Book (P/B) ratio of 2.00. Compared to its 3-year average P/B ratio of 2.28 , the current P/B ratio is approximately -11.99% higher. Relative to its 5-year average P/B ratio of 8.91, the current P/B ratio is about -77.50% higher. Maravai LifeSciences Holdings Inc (MRVI) has a Forward Free Cash Flow (FCF) yield of approximately -13.45%. Compared to its 3-year average FCF yield of 4.53%, the current FCF yield is approximately -396.76% lower. Relative to its 5-year average FCF yield of 6.77% , the current FCF yield is about -298.75% lower.
P/B
Median3y
2.28
Median5y
8.91
FCF Yield
Median3y
4.53
Median5y
6.77
Competitors Valuation Multiple
AI Analysis for MRVI
The average P/S ratio for MRVI competitors is 128.81, providing a benchmark for relative valuation. Maravai LifeSciences Holdings Inc Corp (MRVI.O) exhibits a P/S ratio of 2.51, which is -98.05% above the industry average. Given its robust revenue growth of -39.69%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for MRVI
1Y
3Y
5Y
Market capitalization of MRVI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MRVI in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MRVI currently overvalued or undervalued?
Maravai LifeSciences Holdings Inc (MRVI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.51 is considered Undervalued compared with the five-year average of 1168.03. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 49.43 to 53.48 according to relative valuation methord. Compared to the current price of 3.91 USD , Maravai LifeSciences Holdings Inc is Undervalued By 92.09% .
What is Maravai LifeSciences Holdings Inc (MRVI) fair value?
MRVI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Maravai LifeSciences Holdings Inc (MRVI) is between 49.43 to 53.48 according to relative valuation methord.
How does MRVI's valuation metrics compare to the industry average?
The average P/S ratio for MRVI's competitors is 128.81, providing a benchmark for relative valuation. Maravai LifeSciences Holdings Inc Corp (MRVI) exhibits a P/S ratio of 2.51, which is -98.05% above the industry average. Given its robust revenue growth of -39.69%, this premium appears unsustainable.
What is the current P/B ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Jan 09 2026?
As of Jan 09 2026, Maravai LifeSciences Holdings Inc (MRVI) has a P/B ratio of 2.00. This indicates that the market values MRVI at 2.00 times its book value.
What is the current FCF Yield for Maravai LifeSciences Holdings Inc (MRVI) as of Jan 09 2026?
As of Jan 09 2026, Maravai LifeSciences Holdings Inc (MRVI) has a FCF Yield of -13.45%. This means that for every dollar of Maravai LifeSciences Holdings Inc’s market capitalization, the company generates -13.45 cents in free cash flow.
What is the current Forward P/E ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Jan 09 2026?
As of Jan 09 2026, Maravai LifeSciences Holdings Inc (MRVI) has a Forward P/E ratio of -15.07. This means the market is willing to pay $-15.07 for every dollar of Maravai LifeSciences Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Maravai LifeSciences Holdings Inc (MRVI) as of Jan 09 2026?
As of Jan 09 2026, Maravai LifeSciences Holdings Inc (MRVI) has a Forward P/S ratio of 2.51. This means the market is valuing MRVI at $2.51 for every dollar of expected revenue over the next 12 months.